Interestingly, HA and activated M2-like TAMs correlate with higher malignancy in breast cancer, where the HA-CD44 interaction induces TAMs via the HA-CD44-ERK1/2-STAT3 pathway [21]. This evidence concerns the gene CD44 and breast carcinoma.